{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T22:44:28Z","timestamp":1777416268159,"version":"3.51.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12886-018-0738-x","type":"journal-article","created":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T06:06:15Z","timestamp":1520316375000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Fundus changes in type III membranoproliferative glomerulonephritis: a case report"],"prefix":"10.1186","volume":"18","author":[{"given":"Masato","family":"Takei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Obana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3435-1055","authenticated-orcid":false,"given":"Takenori","family":"Inomata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina","family":"Shiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Bae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamiko","family":"Takemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,6]]},"reference":[{"issue":"17","key":"738_CR1","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1056\/NEJM199804233381707","volume":"338","author":"SR Orth","year":"1998","unstructured":"Orth SR, Ritz E. The nephrotic syndrome. N Engl J Med. 1998;338(17):1202\u201311.","journal-title":"N Engl J Med"},{"issue":"11","key":"738_CR2","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/nrneph.2012.213","volume":"8","author":"AS Bomback","year":"2012","unstructured":"Bomback AS, Appel GB. Pathogenesis of the C3 glomerulopathies and reclassification of MPGN. Nat Rev Nephrol. 2012;8(11):634\u201342.","journal-title":"Nat Rev Nephrol"},{"issue":"8","key":"738_CR3","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00467-009-1322-7","volume":"25","author":"B Alchi","year":"2010","unstructured":"Alchi B, Jayne D. Membranoproliferative glomerulonephritis. Pediatr Nephrol. 2010;25(8):1409\u201318.","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"738_CR4","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/ICB.0000000000000164","volume":"10","author":"LA Dalvin","year":"2016","unstructured":"Dalvin LA, Fervenza FC, Sethi S, Pulido JS. Shedding light on Fundus Drusen associated with Membranoproliferative Glomerulonephritis: breaking stereotypes of types I, ii, and iii. Retin Cases Brief Rep. 2016;10(1):72\u20138.","journal-title":"Retin Cases Brief Rep"},{"issue":"7","key":"738_CR5","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1055\/s-2003-40937","volume":"220","author":"A Hassenstein","year":"2003","unstructured":"Hassenstein A, Richard G. Choroidal neovascularisation in type II membranoproliferative glomerulonephritis, photodynamic therapy as a treatment option--a case report. Klin Monatsbl Augenheilkd. 2003;220(7):492\u20135.","journal-title":"Klin Monatsbl Augenheilkd"},{"issue":"4","key":"738_CR6","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1055\/s-2008-1034983","volume":"213","author":"C Framme","year":"1998","unstructured":"Framme C, Herboth T, Roider J, Laqua H. Subretinal neovascular membranes in membranoproliferative glomerulonephritis type II. Klin Monatsbl Augenheilkd. 1998;213(4):252\u20133.","journal-title":"Klin Monatsbl Augenheilkd"},{"issue":"4","key":"738_CR7","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/S0002-9394(14)71397-2","volume":"116","author":"MR Ulbig","year":"1993","unstructured":"Ulbig MR, Riordan-Eva P, Holz FG, Rees HC, Hamilton PA. Membranoproliferative glomerulonephritis type II associated with central serous retinopathy. Am J Ophthalmol. 1993;116(4):410\u20133.","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"738_CR8","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1001\/archophthalmol.2009.38","volume":"127","author":"DP Han","year":"2009","unstructured":"Han DP, Sievers S. Extensive drusen in type I membranoproliferative glomerulonephritis. Arch Ophthalmol. 2009;127(4):577\u20139.","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"738_CR9","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1136\/bjo.73.4.297","volume":"73","author":"J Duvall-Young","year":"1989","unstructured":"Duvall-Young J, MacDonald MK, McKechnie NM. Fundus changes in (type II) mesangiocapillary glomerulonephritis simulating drusen: a histopathological report. Br J Ophthalmol. 1989;73(4):297\u2013302.","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"738_CR10","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1136\/bjo.73.11.900","volume":"73","author":"J Duvall-Young","year":"1989","unstructured":"Duvall-Young J, Short CD, Raines MF, Gokal R, Lawler W. Fundus changes in mesangiocapillary glomerulonephritis type II: clinical and fluorescein angiographic findings. Br J Ophthalmol. 1989;73(11):900\u20136.","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"738_CR11","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/BF00142681","volume":"76","author":"B Michielsen","year":"1990","unstructured":"Michielsen B, Leys A, Van Damme B, Missotten L. Fundus changes in chronic membranoproliferative glomerulonephritis type II. Doc Ophthalmol. 1990;76(3):219\u201329.","journal-title":"Doc Ophthalmol"},{"issue":"4","key":"738_CR12","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.krcp.2014.07.006","volume":"33","author":"SA Woo","year":"2014","unstructured":"Woo SA, Young Ju H, Hyo Kwon S, Lee JH, Jeong Choi S, Cheol Han D, Duk Hwang S, Hong SY, Jin SY, Gil HW. Reanalysis of membranoproliferative glomerulonephritis patients according to the new classification: a multicenter study. Kidney Res Clin Pract. 2014;33(4):187\u201391.","journal-title":"Kidney Res Clin Pract"},{"issue":"7","key":"738_CR13","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1016\/j.ophtha.2016.02.018","volume":"123","author":"LA Dalvin","year":"2016","unstructured":"Dalvin LA, Fervenza FC, Sethi S, Pulido JS. Manifestations of complement-mediated and immune complex-mediated Membranoproliferative Glomerulonephritis: a comparative consecutive series. Ophthalmology. 2016;123(7):1588\u201394.","journal-title":"Ophthalmology"},{"issue":"Pt 3","key":"738_CR14","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/eye.2001.142","volume":"15","author":"RF Mullins","year":"2001","unstructured":"Mullins RF, Aptsiauri N, Hageman GS. Structure and composition of drusen associated with glomerulonephritis: implications for the role of complement activation in drusen biogenesis. Eye. 2001;15(Pt 3):390\u20135.","journal-title":"Eye"},{"issue":"5","key":"738_CR15","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/S0002-9394(14)74489-7","volume":"114","author":"DD Kim","year":"1992","unstructured":"Kim DD, Mieler WF, Wolf MD. Posterior segment changes in membranoproliferative glomerulonephritis. Am J Ophthalmol. 1992;114(5):593\u20139.","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"738_CR16","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/BF00918479","volume":"228","author":"A Leys","year":"1990","unstructured":"Leys A, Michielsen B, Leys M, Vanrenterghem Y, Missotten L, Van Damme B. Subretinal neovascular membranes associated with chronic membranoproliferative glomerulonephritis type II. Graefes Arch Clin Exp Ophthalmol. 1990;228(6):499\u2013504.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"738_CR17","doi-asserted-by":"crossref","unstructured":"McCullagh D, Silvestri G, Maxwell AP. Treatment of choroidal neovascularisation secondary to membranoproliferative glomerulonephritis type II with intravitreal ranibizumab. BMJ Case Rep. 2014;2014.","DOI":"10.1136\/bcr-2013-010247"},{"key":"738_CR18","first-page":"864198","volume":"2012","author":"T Empeslidis","year":"2012","unstructured":"Empeslidis T, Imrani U, Vardarinos A, Menassa N, Banerjee S. Spontaneous resolution of retinal pigment epithelial detachments and visual improvement in patient with MPGN II: a case report. Case Rep Ophthalmol Med. 2012;2012:864198.","journal-title":"Case Rep Ophthalmol Med"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-018-0738-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,12]],"date-time":"2019-10-12T04:17:38Z","timestamp":1570853858000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-018-0738-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,6]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["738"],"URL":"https:\/\/doi.org\/10.1186\/s12886-018-0738-x","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,6]]},"assertion":[{"value":"24 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"72"}}